- Home
- / Hubei Guangji Pharmaceutical
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Hubei Guangji Pharmaceutical financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
¥5.7
2024-10-29
Market Capitalization
¥2 B
2024-10-29
Revenue
¥619.5 M
FY, 2024
CreditSafe Score
?
Score changed on Jun 10, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| CNY | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 |
|---|---|---|---|---|---|---|---|
| Revenue | 813.7M | 705.1M | 673.9M | 820.7M | 781.4M | 716.4M | 619.5M |
| Cost of goods sold | 364.4M | 391.5M | 408.5M | 535.9M | 502.5M | 535.6M | 519.1M |
| Gross profit | 456.4M | 324.1M | 266.6M | 285.3M | 281.6M | 188.5M | 104.1M |
| Gross profit margin, % | 46.0% | 39.6% | 34.8% | 36.0% | 26.3% | 16.8% | |
| Operating expense total | 131.0M | 136.4M | 82.1M | 115.6M | 129.7M | 150.8M | 127.7M |
| Depreciation and amortization | 85.9M | 83.3M | 90.4M | 90.9M | 97.5M | 118.7M | 193.1M |
| EBITDA | 323.0M | 183.5M | 179.8M | 186.8M | 156.3M | 37.7M | (51.5M) |
| EBITDA margin, % | 26.0% | 26.7% | 22.8% | 20.0% | 5.3% | -8.3% | |
| EBIT | 243.1M | 135.6M | 93.1M | 121.4M | 69.0M | (86.9M) | (236.4M) |
| EBIT margin, % | 19.2% | 13.8% | 14.8% | 8.8% | -12.1% | -38.2% | |
| Interest income | 566.0K | 1.1M | 1.4M | 3.2M | 2.0M | 3.5M | 2.1M |
| Interest expense | 30.7M | 32.4M | 32.0M | 16.7M | 21.1M | 49.2M | 62.0M |
| Pre tax profit | 207.1M | 99.9M | 88.1M | 124.3M | 60.1M | (140.7M) | (320.3M) |
| Income tax expense | 33.7M | 16.7M | 17.8M | 18.5M | 12.4M | 11.7M | (5.2M) |
| Net Income | 173.4M | 83.2M | 70.3M | 105.8M | 47.7M | (152.4M) | (315.1M) |